Role of cathepsin S-dependent epithelial cell apoptosis in IFN-γ-induced alveolar remodeling and pulmonary emphysema

Journal of Immunology

Volumn 174, Issue 12, 2005, Pages 8106-8115

  Zheng, Tao ^a   Kang, Min Jong ^a   Crothers, Kristina ^a   Zhu, Zhou ^a   Liu, Wei ^a   Lee, Chun Geun ^a   Rabach, Lesley A ^a   Chapman, Harold A ^b   Homer, Robert J ^a,c   Aldous, David ^d   DeSanctis, George ^d   Underwood, Stephen ^d   Graupe, Michael ^e   Flavell, Richard A ^a   Schmidt, John A ^d   Elias, Jack A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d SANOFI   (France)

^e CELERA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE INHIBITOR; CATHEPSIN S; DEATH RECEPTOR; GAMMA INTERFERON; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEINASE; PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DNA DAMAGE; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG EMPHYSEMA; LUNG LAVAGE; MOUSE; NICK END LABELING; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; TH1 CELL; TISSUE INJURY;

EID: 20444368841     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.12.8106     Document Type: Article

References (52)

1. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume, D. A. 2004. Interferon-γ: an overview of signals, mechanisms and functions. J. Leukocyte Biol. 75: 163-189.
2. Tellides, G., D. A. Tereb, N. C. Kirkiles-Smith, R. W. Kim, J. H. Wilson, J. S. Schechner, M. I. Lorder, and J. S. Pober. 2000. Interferon-γ elicits arteriosclerosis in the absence of leukocytes. Nature 403: 207-211.
3. Bouma, G., and W. Strober. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533.
4. Sandler, N. G., M. M. Mentink-Kane, A. W. Cheever, and T. A. Wynn. 2003. Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J. Immunol. 171: 3655-3667.
5. Lundin, K. E., 2003. Oats induced villous atrophy in coeliac disease. Gut 52: 1649-1652.
6. Vervoordeldonk, M. J., and P. P. Tak. 2002. Cytokines in rheumatoid arthritis. Curr. Rheumatol Rep. 4: 208-217.
7. Garlet, G. P., W. Martins, Jr., B. R. Ferreira, C. M. Milanezi, and J. S. Silva. 2003. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J. Periodont. Res. 38: 210-217.
8. Ben Ahmed, M., H. Houman, M. Miled, K. Dellagi, and H. Louzir. 2004. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheum. 50: 2291-2295.
9. Borra, R. C., P. M. Andrade, I. D. Silva, A. Morgun, L. L. Weckx, A. S. Smirnova, and M. Franco. 2004. The Th1/Th2 immune-type response of the recurrent aphthous ulceration analyzed by cDNA microarray. J. Oral. Pathol. Med. 33: 140-146.
10. Katakai, T., T. Hara, M. Sugai, H. Gonda, and A. Shimizu. 2003. Th1-biased tertiary lymphoid tissue supported by CXC chemokine ligand 13-producing stromal network in chronic lesions of autoimmune gastritis. J. Immunol. 171: 4359-4368.
11. Foxman, E., F.M. Zhang, S. D. Hurst, T. Muchamuel, D. Shen, E. F. Wawrousek, C. C. Chan, and I. Gery. 2002. Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J. Immunol 168: 2483-2492.
12. Ehlers, S., J. Benini, H. D. Held, C. Roeck, G. Alber, and S. Uhlig. 2001. αβ T cell receptor-positive cells and interferon-γ, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J. Exp. Med. 194: 1847-1859.
13. + T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD. Sarcoidosis Vasc. Diffuse Lung Dis. 20: 28-32.
14. Saetta, M., M. Mariani, P. Panina-Bordignon, G. Turato, C. Buonsanti, S. Baraldo, C. M. Bellettato, A. Papi, L. Corbetta, R. Zuin, et al. 2002. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 165: 1404-1409.
15. Saetta, M., S. Baraldo, L. Corbino, G. Turato, F. Braccioni, F. Rea, G. Cavallesco, G. Tropeano, C. E. Mapp, P. Maestrelli, et al. 1999. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160: 711-717.
16. 1. Am. J. Respir. Crit. Care Med. 155: 852-857.
17. Cosio, M. G., and A. Guerassimov. 1999. Chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160: S21-S25.
18. Grumelli, S., D. B. Corry, L. Z. Song, L. Song, L. Green, J. Huh, J. Hacken, R. Espada, R. Bag, D. E. Lewis, and F. Kheradmano. 2004. An immune basis for lung parenchymal destruction in chronic obstructive lung disease and emphysema. PLoS Med. 1: e8.
19. Wang, Z., T. Zheng, Z. Zhu, R. J. Homer, R. J. Riese, H. A. Chapman, S. D. Shapiro, and J. A. Elias. 2000. Interferon γ induction of pulmonary emphysema in the adult murine lung. J. Exp. Med. 192: 1587-1600.
20. Senior, R. M., and S. D. Shapiro. 1998. Chronic obstructive pulmonary disease: epidemiology, pathophysiology, and pathogenesis. In Fishman's Pulmonary Diseases and Disorders, Vol. 1. A. P. Fishman, et al., eds. McGraw-Hill, New York, pp. 659-681.
21. Sutherland, E. R., and R. M. Cherniack. 2004. Management of chronic obstructive pulmonary disease. N. Engl. J. Med. 350: 2689-2697.
22. Hogg, J. C., F. Chu, S. Utokaparch, R. Woods, W. M. Elliott, L. Buzata. R. M. Cherniack, R. M. Rogers, F. C. Sciurba, H. O. Coxson, and P. D. Pare. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350: 2645-2653.
23. Saetta, M. 1999. Airway inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160: 517-520.
24. Majo, J., H. Ghezzo, and M. G. Cosio. 2001. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur. Respir. J. 17: 946-953.
25. Aoshiba, K., N. Yokohori, and A. Nagai. 2003. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am. J. Respir. Cell Mol. Biol. 28: 555-562.
26. Segura-Valdez, L., A. Pardo, M. Gaxiola, B. D. Uhal, C. Becerril, and M. Selman. 2000. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 117: 684-694.
27. Kasahara, Y., R. M. Tuder, L. Taraseviciene-Stewart, T. D. Le Cras, S. Abman, P. K. Hirth, J. Waltenberger, and N. F. Voelkel. 2000. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 106: 1311-1319.
28. Kasahara, Y., R. M. Tuder, C. D. Cool, D. A. Lynch, S. C. Flores, and N. F. Voelkel. 2001. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. 163: 737-744.
29. Shi, G. P., J. A. Villadangos, G. Dranoff, C. Small, L. Gu, K. J. Haley, R. Riese, H. L. Ploegh, and H. A. Chapman. 1999. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10: 197-206.
30. Kuida, K., T. S. Zheng, S. Na, C. Kuan, D. Yang, H. Karasuyama, P. Rakic, and R. A. Flavell. 1996. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368-372.
31. Le, D. A., Y. Wu, Z. Huang, K. Matsushita, N. Plesnila, J. C. Augustinack, B. T. Hyman, J. Yuan, K. Kuida, R. A. Flavell, and M. A. Moskowitz. 2002. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl. Acad. Sci. USA 99: 15188-15193.
32. Lee, C. G., S. J. Cho, M. J. Kang, S. P. Chapoval, P. J. Lee, P. W. Noble, T. Yehualaeshet, B. Lu, R. A. Flavell, J. Milbrandt, et al. 2004. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor β1-induced pulmonary fibrosis. J. Exp. Med. 200: 377-389.
33. Corti, M., A. R. Brody, and J. H. Harrison. 1996. Isolation and primary culture of murine alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14: 309-315.
34. Zheng, T., Z. Zhu, Z. Wang, R. J. Homer, B. Ma, R. J. Riese, Jr., H. A. Chapman, Jr., S. D. Shapiro, and J. A. Elias. 2000. Indudble targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J. Clin. Invest. 106: 1081-1093.
35. Joza, N., G. Kroemer, and J. M. Penninger. 2002. Genetic analysis of the mammalian cell death machinery. Trends Genet. 18: 142-149.
36. Leist, M., and M. Jaattela. 2001. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 1: 589-598.
37. Li, J. H., M. S. Kluger, L. A. Madge, L. Zheng, A. L. Bothwell, and J. S. Pober. 2002. Interferon-γ augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Am. J. Pathol. 161: 1485-1495.
38. Wang, W. J., J. C. Kuo, C. C. Yao, and R. H. Chen. 2002. DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J. Cell Biol 159: 169-179.
39. Zheng, H., R. C. Luo, L. S. Zhang, and G. F. Mai. 2002. Interferon-γ up-regulates Fas expression and increases Fas-mediated apoptosis in tumor cell lines. Di Yi Jun Yi Da Xue Xue Bao. 22: 1090-1102.
40. Shi, G. P., A. C. Webb, K. E. Foster, J. H. Knoll, C. A. Lemere, J. S. Munger, and H. A. Chapman. 1994. Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J. Biol. Chem. 269: 11530-11536.
41. Sukhova, G. K., Y. Zhang, J. H. Pan, Y. Wade, T. Yamamoto, M. Naito, T. Kodama, S. Tsimikas, J. L. Witztum, M. L. Lu, et al. 2003. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 111: 897-906.
42. Jormsjo, S., D. M. Wuttge, A. Sirsjo, C. Whatling, A. Hamsten, S. Stemme, and P. Eriksson. 2002. Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice, Am. J. Pathol. 161: 939-945.
43. Foghsgaard, L., D. Wissing, D. Mauch, U. Lademann, L. Bastholm, M. Boes, F. Elling, M. Leist, and M. Jaattela. 2001. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153: 999-1010.
44. Ferri, K. F., and G. Kroemer. 2001. Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3: E255-E263.
45. Guicciardi, M. E., J. Deussing, H. Miyoshi, S. F. Bronk, P. A. Syingen, C. Peters, S. H. Kaufmann, and G. J. Gores. 2000. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106: 1127-1137.
46. Lotem, J., and L. Sachs. 1996. Differential suppression by protease inhibitors and cytokines of apoptosis induced by wild-type p53 and cytotoxic agents. Proc. Natl. Acad. Sci. USA 93: 12507-12512.
47. Vancompernolle, K., F. Van Herreweghe, G. Pynaert, M. Van de Craen, K. de Vos, N. Totty, A. Sterling, W. Fiers, P. Vandenabeele, and J. Grooten. 1998. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett. 438: 150-158.
48. Hodge, S., G. Hodge, R. Scicchitano, P. N. Reynolds, and M. Holmes. 2003. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol. Cell Biol. 81: 289-296.
49. Kirkham, P. A., G. Spooner, I. Rahman, and A. G. Rossi. 2004. Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation products. Biochem. Biophys. Res. Commun. 318: 32-37.
50. Wang, L., J. M. Antonini, Y. Rojanasakul, V. Castranova, J. F. Scabilloni, and R. R. Mercer. 2003. Potential role of apoptotic macrophages in pulmonary inflammation and fibrosis. J. Cell Physiol. 194: 215-224.
51. Savill, J., and C. Haslett. 1995. Granulocyte clearance by apoptosis in the resolution of inflammation. Semin. Cell Biol. 6: 385-393.
52. Katunuma, N., Y. Matsunaga, K. Himeno, and Y. Hayashi. 2003. Insights into the roles of cathepsins in antigen processing and presentation revealed by specific inhibitors. Biol. Chem. 384: 883-890.